Abstract

Case Study

An Interesting Case of COPD Exacerbation Presenting with Mixed Features of Intracranial Hypertension and Hypercapnic Encephalopathy

Chaoneng Wu*, Gustavo Mendez, Aaron Gandhi, Sujata Kambhatla, Furqan Siddiqui, Amin Pasha and Ramesh Madhavan*

Published: 02 July, 2024 | Volume 8 - Issue 2 | Pages: 035-041

Background: Idiopathic intracranial hypertension (IIH or pseudotumor cerebri) has two major morbidities: papilledema with visual loss and disabling headache. Intracranial Venous Hypertension (IVH) is a fundamental mechanism of IIH. Although traditionally considered limiting to the central nervous system, evidence suggests IIH as a systemic disease associated with cardiorespiratory disorders, which has been far less comprehended. 
Case Report: A 60-year-old female with Chronic Obstructive Pulmonary Disease (COPD) was admitted for dyspnea and developed a coma with a pH of 7.01 and pCO2 of 158 mmHg. She was intubated and had persistent nuchal rigidity, a brief myoclonus episode with a negative electroencephalogram, and negative CT head studies. A Lumbar Puncture (LP) revealed elevated opening pressure (35 cmH2O) with normal Cerebral Spinal Fluid (CSF) studies. Her nuchal rigidity improved after the removal of 40 mL CSF. The ophthalmology examination the next day after her the large volume LP didn’t show visual loss or papilledema. The patient improved clinically and was extubated two days later. Her echocardiogram showed a dilated right ventricle with pulmonary hypertension. The patient was discharged home.
Discussion: IIH is different from hypercapnic encephalopathy and characterized by increased intracranial pressure with papilledema, vision loss, and debilitating headache. Hypercapnia-induced increased intracranial venous flow and pulmonary hypertension-caused elevated central venous pressure with consequent outflow resistance lead to IVH. In hypercapnic encephalopathy, the presentation is mostly cognitive changes. In this case, nuchal rigidity with a negative CT head scan triggered the investigation of IIH. 
Conclusion: A deep understanding of the relationship between COPD and IIH is vital. There is insufficient evidence to recommend routine eye examinations in COPD patients for papilledema and to conduct a pulmonary function test for a newly diagnosed IIH patient. However, we highly suggest a timely ophthalmology exam prior to performing an LP in COPD patients with suspecting IIH to avoid unnecessary procedures and meanwhile improve clinical outcomes.

Read Full Article HTML DOI: 10.29328/journal.jprr.1001056 Cite this Article Read Full Article PDF

Keywords:

Hypercapnia; Pulmonary hypertension; Intracranial venous hypertension; Idiopathic intracranial hypertension; Papilledema; Intractable headache

References

  1. Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, Krishnan A, Chavda SV, Ramalingam S, Edwards J, Hemmings K, Williamson M, Burdon MA, Hassan-Smith G, Digre K, Liu GT, Jensen RH, Sinclair AJ. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1088-1100. doi: 10.1136/jnnp-2017-317440. Epub 2018 Jun 14. PMID: 29903905; PMCID: PMC6166610.
  2. Wakerley BR, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: Update on diagnosis and management. Clin Med (Lond). 2020 Jul;20(4):384-388. doi: 10.7861/clinmed.2020-0232. PMID: 32675143; PMCID: PMC7385768.
  3. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013 Sep 24;81(13):1159-65. doi: 10.1212/WNL.0b013e3182a55f17. Epub 2013 Aug 21. PMID: 23966248.
  4. Miah L. et al. 204 Idiopathic intracranial hypertension in Wales: population characterisation, epidemiological trends and healthcare utilisation. Neurol. Neurosurg. Psychiatry. 2022. doi:10.1136/jnnp-2022-abn.233.
  5. McCluskey G, Doherty-Allan R, McCarron P, Loftus AM, McCarron LV, Mulholland D, McVerry F, McCarron MO. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol. 2018 Oct;25(10):1218-1227. doi: 10.1111/ene.13739. Epub 2018 Aug 3. PMID: 29953685.
  6. Smit M, Werner MJM, Lansink-Hartgring AO, Dieperink W, Zijlstra JG, van Meurs M. How central obesity influences intra-abdominal pressure: a prospective, observational study in cardiothoracic surgical patients. Ann Intensive Care. 2016 Dec;6(1):99. doi: 10.1186/s13613-016-0195-8. Epub 2016 Oct 10. PMID: 27726116; PMCID: PMC5056912.
  7. Fargen KM. Idiopathic intracranial hypertension is not idiopathic: Proposal for a new nomenclature and patient classification. Journal of NeuroInterventional Surgery. https://doi.org/10.1136/neurintsurg-2019-015498.
  8. Yiangou A, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms. Nat Rev Neurol. 2023 Dec;19(12):769-785. doi: 10.1038/s41582-023-00893-0. Epub 2023 Nov 13. PMID: 37957260.
  9. Thurtell MJ, Bruce BB, Rye DB, Newman NJ, Biousse V. The Berlin questionnaire screens for obstructive sleep apnea in idiopathic intracranial hypertension. J Neuroophthalmol. 2011 Dec;31(4):316-9. doi: 10.1097/WNO.0b013e31821a4d54. PMID: 21537196; PMCID: PMC3433717.
  10. Kok LT, Gnoni V, Muza R, Nesbitt A, Leschziner G, Wong SH. Prevalence and utility of overnight pulse oximetry as a screening tool for obstructive sleep apnoea in newly diagnosed idiopathic intracranial hypertension. Eye (Lond). 2023 Feb;37(3):537-542. doi: 10.1038/s41433-022-01971-1. Epub 2022 Feb 24. PMID: 35210570; PMCID: PMC8867690.
  11. Pepin SM. Salcone EM. Idiopathic intracranial hypertension and asthma: Evidence for an association. Ophthalmol. Vis. Sci. 2004; 45:1607.
  12. Scala R. Hypercapnic encephalopathy syndrome: a new frontier for non-invasive ventilation? Respir Med. 2011 Aug;105(8):1109-17. doi: 10.1016/j.rmed.2011.02.004. Epub 2011 Feb 26. PMID: 21354774.
  13. Remzső G, Németh J, Tóth-Szűki V, Varga V, Kovács V, Domoki F. NMDA attenuates the neurovascular response to hypercapnia in the neonatal cerebral cortex. Sci Rep. 2019 Dec 11;9(1):18900. doi: 10.1038/s41598-019-55468-1. PMID: 31827200; PMCID: PMC6906464.
  14. ROBIN ED. Abnormalities of acid-base regulation in chronic pulmonary disease, with special reference to hypercapnia and extracellular alkalosis. N Engl J Med. 1963 Apr 25;268:917-22. doi: 10.1056/NEJM196304252681703. PMID: 13974389.
  15. Van Yperselle de Striho, Brasseur L, De Coninck JD. The "carbon dioxide response curve" for chronic hypercapnia in man. N Engl J Med. 1966 Jul 21;275(3):117-22. doi: 10.1056/NEJM196607212750301. PMID: 5943727.
  16. Farahvash A, Micieli JA. Neuro-Ophthalmological Manifestations of Obstructive Sleep Apnea: Current Perspectives. Eye Brain. 2020 Jul 7;12:61-71. doi: 10.2147/EB.S247121. PMID: 32753994; PMCID: PMC7353992.
  17. Fraser JA, Bruce BB, Rucker J, Fraser LA, Atkins EJ, Newman NJ, Biousse V. Risk factors for idiopathic intracranial hypertension in men: a case-control study. J Neurol Sci. 2010 Mar 15;290(1-2):86-9. doi: 10.1016/j.jns.2009.11.001. Epub 2009 Nov 30. PMID: 19945715; PMCID: PMC2815168.
  18. Thurtell MJ, Trotti LM, Bixler EO, Rye DB, Bliwise DL, Newman NJ, Biousse V, Bruce BB. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data. J Neurol. 2013 Jul;260(7):1748-51. doi: 10.1007/s00415-013-6858-6. Epub 2013 Feb 15. PMID: 23412355; PMCID: PMC3707935.
  19. Weed LH. Some Limitations Of The Monro-Kellie Hypothesis. Surg. 1929. doi:10.1001/archsurg.1929.01140130137006.
  20. Chesnut RM, Temkin N, Carney N, Dikmen S, Rondina C, Videtta W, Petroni G, Lujan S, Pridgeon J, Barber J, Machamer J, Chaddock K, Celix JM, Cherner M, Hendrix T; Global Neurotrauma Research Group. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012 Dec 27;367(26):2471-81. doi: 10.1056/NEJMoa1207363. Epub 2012 Dec 12. Erratum in: N Engl J Med. 2013 Dec 19;369(25):2465. PMID: 23234472; PMCID: PMC3565432.
  21. Weinberger SE, Schwartzstein RM, Weiss JW. Hypercapnia. N Engl J Med. 1989 Nov 2;321(18):1223-31. doi: 10.1056/NEJM198911023211804. PMID: 2677729.
  22. Mathews AM, Wysham NG, Xie J, Qin X, Giovacchini CX, Ekström M, MacIntyre NR. Hypercapnia in Advanced Chronic Obstructive Pulmonary Disease: A Secondary Analysis of the National Emphysema Treatment Trial. Chronic Obstr Pulm Dis. 2020 Oct;7(4):336-345. doi: 10.15326/jcopdf.7.4.2020.0176. PMID: 32877962; PMCID: PMC7883913.
  23. Jennum P, Børgesen SE. Intracranial pressure and obstructive sleep apnea. Chest. 1989 Feb;95(2):279-83. doi: 10.1378/chest.95.2.279. PMID: 2914475.
  24. Zhang Z, Guo Q, Wang E. Hyperventilation in neurological patients: from physiology to outcome evidence. Curr Opin Anaesthesiol. 2019 Oct;32(5):568-573. doi: 10.1097/ACO.0000000000000764. PMID: 31211719; PMCID: PMC6735527.
  25. Godoy DA, Seifi A, Garza D, Lubillo-Montenegro S, Murillo-Cabezas F. Hyperventilation Therapy for Control of Posttraumatic Intracranial Hypertension. Front Neurol. 2017 Jul 17;8:250. doi: 10.3389/fneur.2017.00250. PMID: 28769857; PMCID: PMC5511895.
  26. Hearon CM Jr, Dias KA, Babu G, Marshall JET, Leidner J, Peters K, Silva E, MacNamara JP, Campain J, Levine BD. Effect of Nightly Lower Body Negative Pressure on Choroid Engorgement in a Model of Spaceflight-Associated Neuro-ocular Syndrome: A Randomized Crossover Trial. JAMA Ophthalmol. 2022 Jan 1;140(1):59-65. doi: 10.1001/jamaophthalmol.2021.5200. PMID: 34882176; PMCID: PMC8662537.
  27. Harris KM, Petersen LG, Weber T. Reviving lower body negative pressure as a countermeasure to prevent pathological vascular and ocular changes in microgravity. NPJ Microgravity. 2020 Dec 17;6(1):38. doi: 10.1038/s41526-020-00127-3. PMID: 33335101; PMCID: PMC7746725.
  28. Hansen AB, Lawley JS, Rickards CA, Howden EJ, Sarma S, Cornwell WK 3rd, Amin SB, Mugele H, Marume K, Possnig C, Whitworth LA, Williams MA, Levine BD. Reducing intracranial pressure by reducing central venous pressure: assessment of potential countermeasures to spaceflight-associated neuro-ocular syndrome. J Appl Physiol (1985). 2021 Feb 1;130(2):283-289. doi: 10.1152/japplphysiol.00786.2020. Epub 2020 Dec 3. PMID: 33270516.
  29. Wilson MH. Monro-Kellie 2.0: The dynamic vascular and venous pathophysiological components of intracranial pressure. J Cereb Blood Flow Metab. 2016 Aug;36(8):1338-50. doi: 10.1177/0271678X16648711. Epub 2016 May 12. PMID: 27174995; PMCID: PMC4971608.
  30. Raisis JE, Kindt GW, McGillicuddy JE, Giannotta SL. The effects of primary elevation of cerebral venous pressure on cerebral hemodynamics and intracranial pressure. J Surg Res. 1979 Feb;26(2):101-7. doi: 10.1016/0022-4804(79)90085-4. PMID: 106185.
  31. Luce JM, Huseby JS, Kirk W, Butler J. A Starling resistor regulates cerebral venous outflow in dogs. J Appl Physiol Respir Environ Exerc Physiol. 1982 Dec;53(6):1496-1503. doi: 10.1152/jappl.1982.53.6.1496. PMID: 6759493.
  32. Hassanzadeh Rad A, Aminzadeh V. Pseudotumor Cerebri Presenting by Neck Rigidity and Torticollis. Iran J Child Neurol. 2023 Winter;17(1):119-123. doi: 10.22037/ijcn.v17i1.32415. Epub 2023 Jan 1. PMID: 36721832; PMCID: PMC9881831.
  33. Straussberg R, Harel L, Amir J. Pseudotumor cerebri manifesting as stiff neck and torticollis. Pediatr Neurol. 2002 Mar;26(3):225-7. doi: 10.1016/s0887-8994(01)00364-2. PMID: 11955932.
  34. Tagoe NN, Beyuo VM, Amissah-Arthur KN. Case series of six patients diagnosed and managed for idiopathic intracranial hypertension at a tertiary institution eye centre. Ghana Med J. 2019 Mar;53(1):79-87. doi: 10.4314/gmj.v53i1.12. PMID: 31138948; PMCID: PMC6527823.
  35. Magliozzi R, Howell OW, Calabrese M, Reynolds R. Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis. Nat Rev Neurol. 2023 Aug;19(8):461-476. doi: 10.1038/s41582-023-00838-7. Epub 2023 Jul 3. PMID: 37400550.
  36. van Olst L, Rodriguez-Mogeda C, Picon C, Kiljan S, James RE, Kamermans A, van der Pol SMA, Knoop L, Michailidou I, Drost E, Franssen M, Schenk GJ, Geurts JJG, Amor S, Mazarakis ND, van Horssen J, de Vries HE, Reynolds R, Witte ME. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration. Acta Neuropathol. 2021 Jun;141(6):881-899. doi: 10.1007/s00401-021-02293-4. Epub 2021 Mar 29. PMID: 33779783; PMCID: PMC8113309.
  37. Barkatullah AF, Leishangthem L, Moss HE. MRI findings as markers of idiopathic intracranial hypertension. Curr Opin Neurol. 2021 Feb 1;34(1):75-83. doi: 10.1097/WCO.0000000000000885. PMID: 33230036; PMCID: PMC7856277.
  38. Chen BS, Meyer BI, Saindane AM, Bruce BB, Newman NJ, Biousse V. Prevalence of Incidentally Detected Signs of Intracranial Hypertension on Magnetic Resonance Imaging and Their Association With Papilledema. JAMA Neurol. 2021 Jun 1;78(6):718-725. doi: 10.1001/jamaneurol.2021.0710. PMID: 33871552; PMCID: PMC8056310.
  39. Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, Hopson D. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982 Aug;39(8):461-74. doi: 10.1001/archneur.1982.00510200003001. PMID: 7103794.
  40. Bouffard MA. Fulminant Idiopathic Intracranial Hypertension. Curr Neurol Neurosci Rep. 2020 Mar 26;20(4):8. doi: 10.1007/s11910-020-1026-8. PMID: 32219578.
  41. Zhao K, Gu W, Liu C, Kong D, Zheng C, Chen W, Li X, Liang Y, Zhou H. Advances in the Understanding of the Complex Role of Venous Sinus Stenosis in Idiopathic Intracranial Hypertension. J Magn Reson Imaging. 2022 Sep;56(3):645-654. doi: 10.1002/jmri.28177. Epub 2022 Mar 31. PMID: 35357056; PMCID: PMC9541264.
  42. Liu KC, Starke RM, Durst CR, Wang TR, Ding D, Crowley RW, Newman SA. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study. J Neurosurg. 2017 Nov;127(5):1126-1133. doi: 10.3171/2016.8.JNS16879. Epub 2016 Dec 23. PMID: 28009240.
  43. Ahmad SR, Moss HE. Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension. Semin Neurol. 2019 Dec;39(6):682-691. doi: 10.1055/s-0039-1698744. Epub 2019 Dec 17. PMID: 31847039; PMCID: PMC7713505.
  44. Mitchell JL, Mollan SP, Vijay V, Sinclair AJ. Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension. Curr Opin Neurol. 2019 Jun;32(3):422-431. doi: 10.1097/WCO.0000000000000690. PMID: 30865008; PMCID: PMC6522204.
  45. Sengupta S, Eckstein C, Collins T. The Dilemma of Diagnosing Idiopathic Intracranial Hypertension Without Papilledema in Patients With Chronic Migraine. JAMA Neurol. 2019 Sep 1;76(9):1001-1002. doi: 10.1001/jamaneurol.2019.1696. PMID: 31259997.
  46. Koch-Weser J, Gilmore EB. Benign intracranial hypertension in an adult after tetracycline therapy. JAMA. 1967 Apr 24;200(4):345-7. PMID: 6071479.
  47. Winn BJ, Liao YJ, Horton JC. Intracranial pressure returns to normal about a month after stopping tetracycline antibiotics [1]. Archives of Ophthalmology. https://doi.org/10.1001/archopht.125.8.1137.
  48. Passi SF, Butcher R, Orme DR, Warner JEA, Stoddard GJ, Crum AV, Gouripeddi R, Kirk BH, Digre KB, Katz BJ. Increased Incidence of Pseudotumor Cerebri Syndrome Among Users of Tetracycline Antibiotics. J Neuroophthalmol. 2022 Sep 1;42(3):323-327. doi: 10.1097/WNO.0000000000001536. Epub 2022 Mar 25. PMID: 35427251; PMCID: PMC9588410.

Figures:

Similar Articles

Recently Viewed

  • MRI-based Tumor Habitat Analysis for Treatment Evaluation of Radiotherapy on Esophageal Cancer
    Shaolei Li, Shengguang Zhao, Yongming Dai, Yida He, Hongcheng Yang, Xuekun Zhang, Xiaoyan Chen, Weixiang Qi, Mei Chen, Yibin Zhang, Jiayi Chen, Fuhua Yan, Zenghui Cheng* and Yingli Yang* Shaolei Li, Shengguang Zhao, Yongming Dai, Yida He, Hongcheng Yang, Xuekun Zhang, Xiaoyan Chen, Weixiang Qi, Mei Chen, Yibin Zhang, Jiayi Chen, Fuhua Yan, Zenghui Cheng*, Yingli Yang*. MRI-based Tumor Habitat Analysis for Treatment Evaluation of Radiotherapy on Esophageal Cancer. J Radiol Oncol. 2024: doi: 10.29328/journal.jro.1001065; 8: 055-063
  • Exit Site Care in Peritoneal Dialysis: Silver as a Possible Strategy?
    Paribello Giuseppe*, Papa Fortuna, Ganzerli Maria Chiara, Del Prete Chiara, Capuano Ivana, Pacella Daniela, Sannino Giuseppina, Rompianesi Gianluca, Pisani Antonio and Riccio Eleonora Paribello Giuseppe*, Papa Fortuna, Ganzerli Maria Chiara, Del Prete Chiara, Capuano Ivana, Pacella Daniela, Sannino Giuseppina, Rompianesi Gianluca, Pisani Antonio, Riccio Eleonora. Exit Site Care in Peritoneal Dialysis: Silver as a Possible Strategy?. J Clini Nephrol. 2024: doi: 10.29328/journal.jcn.1001121; 8: 017-022
  • Orofacial manifestations of COVID-19
    Hariharan Ramakrishnan* and Maniamuthu Ragupathi Hariharan Ramakrishnan*,Maniamuthu Ragupathi. Orofacial manifestations of COVID-19 . J Oral Health Craniofac Sci. 2021: doi: 10.29328/journal.johcs.1001034; 6: 006-007
  • Sinonasal Myxoma Extending into the Orbit in a 4-Year Old: A Case Presentation
    Julian A Purrinos* and Ramzi Younis Julian A Purrinos*, Ramzi Younis. Sinonasal Myxoma Extending into the Orbit in a 4-Year Old: A Case Presentation. Arch Case Rep. 2024: doi: 10.29328/journal.acr.1001099; 8: 075-077
  • Environmental Factors Affecting the Concentration of DNA in Blood and Saliva Stains: A Review
    Divya Khorwal*, GK Mathur, Umema Ahmed and SS Daga Divya Khorwal*, GK Mathur, Umema Ahmed, SS Daga. Environmental Factors Affecting the Concentration of DNA in Blood and Saliva Stains: A Review. J Forensic Sci Res. 2024: doi: 10.29328/journal.jfsr.1001057; 8: 009-015

Read More

Most Viewed

Read More

Help ?